Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets
Clinical trial NCT07519265 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07519265
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-09
- Primary completion
- 2026-08-10
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.